Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cabazitaxel for prostate cancer that has started to get worse after having hormone therapy and docetaxel (CANTATA)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 2

Details

This trial wanted to compare the chemotherapy drugs cabazitaxel and docetaxel for prostate cancer that has spread to other parts of the body. The men had prostate cancer that started to get worse after having both hormone therapy and docetaxel.

This trial was supported by Cancer Research UK.

Recruitment start: 7 March 2013

Recruitment end: 12 February 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Nick James

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Sanofi

University of Birmingham

Other information

This is Cancer Research UK trial number CRUKE/12/031.

Last reviewed: 13 February 2018

CRUK internal database number: 10087

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.